Back to search
Hepatic Impairment (HI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic Impairment (HI) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic Impairment (HI) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers,…
The primary purpose of this study is to evaluate the impact of hepatic function on the pharmacokinetic (PK) profile of pelabresib in participants with advanced…
This clinical research trial is testing the investigational medicinal product (IMP) petrelintide that is being developed for body weight reduction in people liv…
The primary purpose of this study is to evaluate the plasma PK of zanzalintinib following a single dose in participants with moderate liver dysfunction compared…
The purpose of this study is to compare the plasma pharmacokinetics (PK) of nemtabrutinib (MK-1026) following a single oral dose of nemtabrutinib in participant…
The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after a single dose in participants with different levels of…